Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Trichostatin A, by inhibiting histone deacetylase, could lead to hyperacetylation of histones, potentially resulting in the downregulation of OR52B6 by modifying the chromatin structure associated with its gene promoter. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine may incorporate into the OR52B6 gene sequence and competitively inhibit DNA methyltransferases, leading to DNA demethylation and a consequent decrease in OR52B6 expression due to changes in the transcriptional activity of its promoter. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
Suberoylanilide Hydroxamic Acid (Vorinostat) could decrease OR52B6 expression by specifically altering histone acetylation patterns, thereby changing the accessibility of transcriptional machinery to the OR52B6 gene locus. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $54.00 | 6 | |
Mithramycin A might bind selectively to the GC-rich regions in the promoter of the OR52B6 gene, potentially inhibiting the binding of specific transcription factors necessary for OR52B6 transcription initiation. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
Actinomycin D has the potential to intercalate between DNA base pairs at the OR52B6 gene, obstructing RNA polymerase action and consequently leading to a reduction in OR52B6 mRNA synthesis. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $128.00 $505.00 | 2 | |
RG 108 may target DNA methyltransferases, possibly preventing the methylation of the OR52B6 promoter. This could result in an upsurge in transcriptional activity and a subsequent decrease in OR52B6 expression. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $214.00 $316.00 $418.00 | 7 | |
5-Aza-2′-Deoxycytidine (Decitabine) could lead to the hypomethylation of cytosine bases within the OR52B6 promoter region, which might reduce the transcriptional repression mechanisms, culminating in decreased expression of OR52B6. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $88.00 $208.00 | 24 | |
MS-275 (Entinostat), as a selective inhibitor of class I histone deacetylases, might lead to an open chromatin conformation at the OR52B6 locus, potentially reducing the expression levels of the OR52B6 gene. | ||||||
Romidepsin | 128517-07-7 | sc-364603 sc-364603A | 1 mg 5 mg | $214.00 $622.00 | 1 | |
Romidepsin, by inhibiting histone deacetylase, could induce hyperacetylation of histones at the OR52B6 gene, potentially leading to the suppression of its transcriptional activity. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $30.00 $46.00 $82.00 $218.00 | 19 | |
Sodium butyrate, by inhibiting histone deacetylase, could hyperacetylate the histones associated with the OR52B6 gene, potentially disrupting the compact chromatin structure and leading to a subsequent downregulation of OR52B6 expression. | ||||||